MINOR CANNABINOID,
MAJOR POTENTIAL?
Cannabigerol, or CBG, is fi nally making its way onto UK shelves after establishing itself in the US as one to
watch. Meanwhile, the pharmaceutical industry is exploring its potential as a breakthrough medical treatment
in fi ghting superbugs like MRSA. We ask if CBG could become bigger than CBD.
Words by Gordon Stribling
45